Showing 1–16 of 16 results for author: Rando, M

A New Formulation for Zeroth-Order Optimization of Adversarial EXEmples in Malware Detection

Authors: Marco Rando, Luca Demetrio, Lorenzo Rosasco, Fabio Roli

Abstract: Machine learning malware detectors are vulnerable to adversarial EXEmples, i.e. carefully-crafted Windows programs tailored to evade detection. Unlike other adversarial problems, attacks in this context must be functionality-preserving, a constraint which is challenging to address. As a consequence heuristic algorithms are typically used, that inject new content, either randomly-picked or harveste… ▽ More Machine learning malware detectors are vulnerable to adversarial EXEmples, i.e. carefully-crafted Windows programs tailored to evade detection. Unlike other adversarial problems, attacks in this context must be functionality-preserving, a constraint which is challenging to address. As a consequence heuristic algorithms are typically used, that inject new content, either randomly-picked or harvested from legitimate programs. In this paper, we show how learning malware detectors can be cast within a zeroth-order optimization framework which allows to incorporate functionality-preserving manipulations. This permits the deployment of sound and efficient gradient-free optimization algorithms, which come with theoretical guarantees and allow for minimal hyper-parameters tuning. As a by-product, we propose and study ZEXE, a novel zero-order attack against Windows malware detection. Compared to state-of-the-art techniques, ZEXE provides drastic improvement in the evasion rate, while reducing to less than one third the size of the injected content. △ Less

Submitted 23 May, 2024; originally announced May 2024.

Q-Learning to navigate turbulence without a map

Authors: Marco Rando, Martin James, Alessandro Verri, Lorenzo Rosasco, Agnese Seminara

Abstract: We consider the problem of olfactory searches in a turbulent environment. We focus on agents that respond solely to odor stimuli, with no access to spatial perception nor prior information about the odor location. We ask whether navigation strategies to a target can be learned robustly within a sequential decision making framework. We develop a reinforcement learning algorithm using a small set of… ▽ More We consider the problem of olfactory searches in a turbulent environment. We focus on agents that respond solely to odor stimuli, with no access to spatial perception nor prior information about the odor location. We ask whether navigation strategies to a target can be learned robustly within a sequential decision making framework. We develop a reinforcement learning algorithm using a small set of interpretable olfactory states and train it with realistic turbulent odor cues. By introducing a temporal memory, we demonstrate that two salient features of odor traces, discretized in few olfactory states, are sufficient to learn navigation in a realistic odor plume. Performance is dictated by the sparse nature of turbulent plumes. An optimal memory exists which ignores blanks within the plume and activates a recovery strategy outside the plume. We obtain the best performance by letting agents learn their recovery strategy and show that it is mostly casting cross wind, similar to behavior observed in flying insects. The optimal strategy is robust to substantial changes in the odor plumes, suggesting minor parameter tuning may be sufficient to adapt to different environments. △ Less

Submitted 26 April, 2024; originally announced April 2024.

Comments: 18 pages, 8 figures

An Optimal Structured Zeroth-order Algorithm for Non-smooth Optimization

Authors: Marco Rando, Cesare Molinari, Lorenzo Rosasco, Silvia Villa

Abstract: Finite-difference methods are a class of algorithms designed to solve black-box optimization problems by approximating a gradient of the target function on a set of directions. In black-box optimization, the non-smooth setting is particularly relevant since, in practice, differentiability and smoothness assumptions cannot be verified. To cope with nonsmoothness, several authors use a smooth approx… ▽ More Finite-difference methods are a class of algorithms designed to solve black-box optimization problems by approximating a gradient of the target function on a set of directions. In black-box optimization, the non-smooth setting is particularly relevant since, in practice, differentiability and smoothness assumptions cannot be verified. To cope with nonsmoothness, several authors use a smooth approximation of the target function and show that finite difference methods approximate its gradient. Recently, it has been proved that imposing a structure in the directions allows improving performance. However, only the smooth setting was considered. To close this gap, we introduce and analyze O-ZD, the first structured finite-difference algorithm for non-smooth black-box optimization. Our method exploits a smooth approximation of the target function and we prove that it approximates its gradient on a subset of random {\em orthogonal} directions. We analyze the convergence of O-ZD under different assumptions. For non-smooth convex functions, we obtain the optimal complexity. In the non-smooth non-convex setting, we characterize the number of iterations needed to bound the expected norm of the smoothed gradient. For smooth functions, our analysis recovers existing results for structured zeroth-order methods for the convex case and extends them to the non-convex setting. We conclude with numerical simulations where assumptions are satisfied, observing that our algorithm has very good practical performances. △ Less

Submitted 6 November, 2023; v1 submitted 25 May, 2023; originally announced May 2023.

Comments: 37 pages, 6 figures

MSC Class: 90C56 (Primary) 49J52; 90C25; 90C26; 90C30 (Secondary) ACM Class: G.1.6

Fast kernel methods for Data Quality Monitoring as a goodness-of-fit test

Authors: Gaia Grosso, Nicolò Lai, Marco Letizia, Jacopo Pazzini, Marco Rando, Lorenzo Rosasco, Andrea Wulzer, Marco Zanetti

Abstract: We here propose a machine learning approach for monitoring particle detectors in real-time. The goal is to assess the compatibility of incoming experimental data with a reference dataset, characterising the data behaviour under normal circumstances, via a likelihood-ratio hypothesis test. The model is based on a modern implementation of kernel methods, nonparametric algorithms that can learn any c… ▽ More We here propose a machine learning approach for monitoring particle detectors in real-time. The goal is to assess the compatibility of incoming experimental data with a reference dataset, characterising the data behaviour under normal circumstances, via a likelihood-ratio hypothesis test. The model is based on a modern implementation of kernel methods, nonparametric algorithms that can learn any continuous function given enough data. The resulting approach is efficient and agnostic to the type of anomaly that may be present in the data. Our study demonstrates the effectiveness of this strategy on multivariate data from drift tube chamber muon detectors. △ Less

Submitted 9 March, 2023; originally announced March 2023.

Comments: 16 pages, 7 figures

A fast and flexible machine learning approach to data quality monitoring

Authors: Gaia Grosso, Nicolò Lai, Marco Letizia, Jacopo Pazzini, Marco Rando, Andrea Wulzer, Marco Zanetti

Abstract: We present a machine learning based approach for real-time monitoring of particle detectors. The proposed strategy evaluates the compatibility between incoming batches of experimental data and a reference sample representing the data behavior in normal conditions by implementing a likelihood-ratio hypothesis test. The core model is powered by recent large-scale implementations of kernel methods, n… ▽ More We present a machine learning based approach for real-time monitoring of particle detectors. The proposed strategy evaluates the compatibility between incoming batches of experimental data and a reference sample representing the data behavior in normal conditions by implementing a likelihood-ratio hypothesis test. The core model is powered by recent large-scale implementations of kernel methods, nonparametric learning algorithms that can approximate any continuous function given enough data. The resulting algorithm is fast, efficient and agnostic about the type of potential anomaly in the data. We show the performance of the model on multivariate data from a drift tube chambers muon detector. △ Less

Submitted 10 March, 2023; v1 submitted 21 January, 2023; originally announced January 2023.

Comments: Accepted at the NeurIPS 2022 workshop: Machine Learning and the Physical Sciences. Full version at arXiv:2303.05413

The Coming of Age of Nucleic Acid Vaccines during COVID-19

Authors: Halie M. Rando, Ronan Lordan, Likhitha Kolla, Elizabeth Sell, Alexandra J. Lee, Nils Wellhausen, Amruta Naik, Jeremy P. Kamil, COVID-19 Review Consortium, Anthony Gitter, Casey S. Greene

Abstract: In the 21st century, several emergent viruses have posed a global threat. Each pathogen has emphasized the value of rapid and scalable vaccine development programs. The ongoing SARS-CoV-2 pandemic has made the importance of such efforts especially clear. New biotechnological advances in vaccinology allow for recent advances that provide only the nucleic acid building blocks of an antigen, eliminat… ▽ More In the 21st century, several emergent viruses have posed a global threat. Each pathogen has emphasized the value of rapid and scalable vaccine development programs. The ongoing SARS-CoV-2 pandemic has made the importance of such efforts especially clear. New biotechnological advances in vaccinology allow for recent advances that provide only the nucleic acid building blocks of an antigen, eliminating many safety concerns. During the COVID-19 pandemic, these DNA and RNA vaccines have facilitated the development and deployment of vaccines at an unprecedented pace. This success was attributable at least in part to broader shifts in scientific research relative to prior epidemics; the genome of SARS-CoV-2 was available as early as January 2020, facilitating global efforts in the development of DNA and RNA vaccines within two weeks of the international community becoming aware of the new viral threat. Additionally, these technologies that were previously only theoretical are not only safe but also highly efficacious. Although historically a slow process, the rapid development of vaccines during the COVID-19 crisis reveals a major shift in vaccine technologies. Here, we provide historical context for the emergence of these paradigm-shifting vaccines. We describe several DNA and RNA vaccines and in terms of their efficacy, safety, and approval status. We also discuss patterns in worldwide distribution. The advances made since early 2020 provide an exceptional illustration of how rapidly vaccine development technology has advanced in the last two decades in particular and suggest a new era in vaccines against emerging pathogens. △ Less

Submitted 24 January, 2023; v1 submitted 14 October, 2022; originally announced October 2022.

Efficient Unsupervised Learning for Plankton Images

Authors: Paolo Didier Alfano, Marco Rando, Marco Letizia, Francesca Odone, Lorenzo Rosasco, Vito Paolo Pastore

Abstract: Monitoring plankton populations in situ is fundamental to preserve the aquatic ecosystem. Plankton microorganisms are in fact susceptible of minor environmental perturbations, that can reflect into consequent morphological and dynamical modifications. Nowadays, the availability of advanced automatic or semi-automatic acquisition systems has been allowing the production of an increasingly large amo… ▽ More Monitoring plankton populations in situ is fundamental to preserve the aquatic ecosystem. Plankton microorganisms are in fact susceptible of minor environmental perturbations, that can reflect into consequent morphological and dynamical modifications. Nowadays, the availability of advanced automatic or semi-automatic acquisition systems has been allowing the production of an increasingly large amount of plankton image data. The adoption of machine learning algorithms to classify such data may be affected by the significant cost of manual annotation, due to both the huge quantity of acquired data and the numerosity of plankton species. To address these challenges, we propose an efficient unsupervised learning pipeline to provide accurate classification of plankton microorganisms. We build a set of image descriptors exploiting a two-step procedure. First, a Variational Autoencoder (VAE) is trained on features extracted by a pre-trained neural network. We then use the learnt latent space as image descriptor for clustering. We compare our method with state-of-the-art unsupervised approaches, where a set of pre-defined hand-crafted features is used for clustering of plankton images. The proposed pipeline outperforms the benchmark algorithms for all the plankton datasets included in our analysis, providing better image embedding properties. △ Less

Submitted 14 September, 2022; originally announced September 2022.

Comments: 13 pages. Accepted at the 26TH International Conference on Pattern Recognition (ICPR 2022)

Application of Traditional Vaccine Development Strategies to SARS-CoV-2

Authors: Halie M. Rando, Ronan Lordan, Alexandra J. Lee, Amruta Naik, Nils Wellhausen, Elizabeth Sell, Likhitha Kolla, COVID-19 Review Consortium, Anthony Gitter, Casey S. Greene

Abstract: Over the past 150 years, vaccines have revolutionized the relationship between people and disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have received attention due to their novelty and successes. However, more traditional vaccine development platforms have also yielded important tools in the worldwide fight against the SARS-CoV-2 virus. A variety of approaches have been… ▽ More Over the past 150 years, vaccines have revolutionized the relationship between people and disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have received attention due to their novelty and successes. However, more traditional vaccine development platforms have also yielded important tools in the worldwide fight against the SARS-CoV-2 virus. A variety of approaches have been used to develop COVID-19 vaccines that are now authorized for use in countries around the world. In this review, we highlight strategies that focus on the viral capsid and outwards, rather than on the nucleic acids inside. These approaches fall into two broad categories: whole-virus vaccines and subunit vaccines. Whole-virus vaccines use the virus itself, either in an inactivated or attenuated state. Subunit vaccines contain instead an isolated, immunogenic component of the virus. Here, we highlight vaccine candidates that apply these approaches against SARS-CoV-2 in different ways. In a companion manuscript, we review the more recent and novel development of nucleic-acid based vaccine technologies. We further consider the role that these COVID-19 vaccine development programs have played in prophylaxis at the global scale. Well-established vaccine technologies have proved especially important to making vaccines accessible in low- and middle-income countries. Vaccine development programs that use established platforms have been undertaken in a much wider range of countries than those using nucleic-acid-based technologies, which have been led by wealthy Western countries. Therefore, these vaccine platforms, though less novel from a biotechnological standpoint, have proven to be extremely important to the management of SARS-CoV-2. △ Less

Submitted 23 January, 2023; v1 submitted 16 August, 2022; originally announced August 2022.

Stochastic Zeroth order Descent with Structured Directions

Authors: Marco Rando, Cesare Molinari, Silvia Villa, Lorenzo Rosasco

Abstract: We introduce and analyze Structured Stochastic Zeroth order Descent (S-SZD), a finite difference approach which approximates a stochastic gradient on a set of $l\leq d$ orthogonal directions, where $d$ is the dimension of the ambient space. These directions are randomly chosen, and may change at each step. For smooth convex functions we prove almost sure convergence of the iterates and a convergen… ▽ More We introduce and analyze Structured Stochastic Zeroth order Descent (S-SZD), a finite difference approach which approximates a stochastic gradient on a set of $l\leq d$ orthogonal directions, where $d$ is the dimension of the ambient space. These directions are randomly chosen, and may change at each step. For smooth convex functions we prove almost sure convergence of the iterates and a convergence rate on the function values of the form $O(d/l k^{-c})$ for every $c<1/2$, which is arbitrarily close to the one of Stochastic Gradient Descent (SGD) in terms of number of iterations. Our bound also shows the benefits of using $l$ multiple directions instead of one. For non-convex functions satisfying the Polyak-Łojasiewicz condition, we establish the first convergence rates for stochastic zeroth order algorithms under such an assumption. We corroborate our theoretical findings in numerical simulations where assumptions are satisfied and on the real-world problem of hyper-parameter optimization, observing that S-SZD has very good practical performances. △ Less

Submitted 15 December, 2022; v1 submitted 10 June, 2022; originally announced June 2022.

Molecular and Serologic Diagnostic Technologies for SARS-CoV-2

Authors: Halie M. Rando, Christian Brueffer, Ronan Lordan, Anna Ada Dattoli, David Manheim, Jesse G. Meyer, Ariel I. Mundo, Dimitri Perrin, David Mai, Nils Wellhausen, COVID-19 Review Consortium, Anthony Gitter, Casey S. Greene

Abstract: The COVID-19 pandemic has presented many challenges that have spurred biotechnological research to address specific problems. Diagnostics is one area where biotechnology has been critical. Diagnostic tests play a vital role in managing a viral threat by facilitating the detection of infected and/or recovered individuals. From the perspective of what information is provided, these tests fall into t… ▽ More The COVID-19 pandemic has presented many challenges that have spurred biotechnological research to address specific problems. Diagnostics is one area where biotechnology has been critical. Diagnostic tests play a vital role in managing a viral threat by facilitating the detection of infected and/or recovered individuals. From the perspective of what information is provided, these tests fall into two major categories, molecular and serological. Molecular diagnostic techniques assay whether a virus is present in a biological sample, thus making it possible to identify individuals who are currently infected. Additionally, when the immune system is exposed to a virus, it responds by producing antibodies specific to the virus. Serological tests make it possible to identify individuals who have mounted an immune response to a virus of interest and therefore facilitate the identification of individuals who have previously encountered the virus. These two categories of tests provide different perspectives valuable to understanding the spread of SARS-CoV-2. Within these categories, different biotechnological approaches offer specific advantages and disadvantages. Here we review the categories of tests developed for the detection of the SARS-CoV-2 virus or antibodies against SARS-CoV-2 and discuss the role of diagnostics in the COVID-19 pandemic. △ Less

Submitted 28 April, 2022; v1 submitted 26 April, 2022; originally announced April 2022.

Learning new physics efficiently with nonparametric methods

Authors: Marco Letizia, Gianvito Losapio, Marco Rando, Gaia Grosso, Andrea Wulzer, Maurizio Pierini, Marco Zanetti, Lorenzo Rosasco

Abstract: We present a machine learning approach for model-independent new physics searches. The corresponding algorithm is powered by recent large-scale implementations of kernel methods, nonparametric learning algorithms that can approximate any continuous function given enough data. Based on the original proposal by D'Agnolo and Wulzer (arXiv:1806.02350), the model evaluates the compatibility between exp… ▽ More We present a machine learning approach for model-independent new physics searches. The corresponding algorithm is powered by recent large-scale implementations of kernel methods, nonparametric learning algorithms that can approximate any continuous function given enough data. Based on the original proposal by D'Agnolo and Wulzer (arXiv:1806.02350), the model evaluates the compatibility between experimental data and a reference model, by implementing a hypothesis testing procedure based on the likelihood ratio. Model-independence is enforced by avoiding any prior assumption about the presence or shape of new physics components in the measurements. We show that our approach has dramatic advantages compared to neural network implementations in terms of training times and computational resources, while maintaining comparable performances. In particular, we conduct our tests on higher dimensional datasets, a step forward with respect to previous studies. △ Less

Submitted 5 April, 2022; originally announced April 2022.

Comments: 22 pages, 13 figures

An Open-Publishing Response to the COVID-19 Infodemic

Authors: Halie M. Rando, Simina M. Boca, Lucy D'Agostino McGowan, Daniel S. Himmelstein, Michael P. Robson, Vincent Rubinetti, Ryan Velazquez, COVID-19 Review Consortium, Casey S. Greene, Anthony Gitter

Abstract: The COVID-19 pandemic catalyzed the rapid dissemination of papers and preprints investigating the disease and its associated virus, SARS-CoV-2. The multifaceted nature of COVID-19 demands a multidisciplinary approach, but the urgency of the crisis combined with the need for social distancing measures present unique challenges to collaborative science. We applied a massive online open publishing ap… ▽ More The COVID-19 pandemic catalyzed the rapid dissemination of papers and preprints investigating the disease and its associated virus, SARS-CoV-2. The multifaceted nature of COVID-19 demands a multidisciplinary approach, but the urgency of the crisis combined with the need for social distancing measures present unique challenges to collaborative science. We applied a massive online open publishing approach to this problem using Manubot. Through GitHub, collaborators summarized and critiqued COVID-19 literature, creating a review manuscript. Manubot automatically compiled citation information for referenced preprints, journal publications, websites, and clinical trials. Continuous integration workflows retrieved up-to-date data from online sources nightly, regenerating some of the manuscript's figures and statistics. Manubot rendered the manuscript into PDF, HTML, LaTeX, and DOCX outputs, immediately updating the version available online upon the integration of new content. Through this effort, we organized over 50 scientists from a range of backgrounds who evaluated over 1,500 sources and developed seven literature reviews. While many efforts from the computational community have focused on mining COVID-19 literature, our project illustrates the power of open publishing to organize both technical and non-technical scientists to aggregate and disseminate information in response to an evolving crisis. △ Less

Submitted 17 September, 2021; originally announced September 2021.

Comments: 10 pages, 4 figures

Journal ref: Proceedings of the Workshop on Digital Infrastructures for Scholarly Content Objects (2021) 29-38

Ada-BKB: Scalable Gaussian Process Optimization on Continuous Domains by Adaptive Discretization

Authors: Marco Rando, Luigi Carratino, Silvia Villa, Lorenzo Rosasco

Abstract: Gaussian process optimization is a successful class of algorithms(e.g. GP-UCB) to optimize a black-box function through sequential evaluations. However, for functions with continuous domains, Gaussian process optimization has to rely on either a fixed discretization of the space, or the solution of a non-convex optimization subproblem at each evaluation. The first approach can negatively affect pe… ▽ More Gaussian process optimization is a successful class of algorithms(e.g. GP-UCB) to optimize a black-box function through sequential evaluations. However, for functions with continuous domains, Gaussian process optimization has to rely on either a fixed discretization of the space, or the solution of a non-convex optimization subproblem at each evaluation. The first approach can negatively affect performance, while the second approach requires a heavy computational burden. A third option, only recently theoretically studied, is to adaptively discretize the function domain. Even though this approach avoids the extra non-convex optimization costs, the overall computational complexity is still prohibitive. An algorithm such as GP-UCB has a runtime of $O(T^4)$, where $T$ is the number of iterations. In this paper, we introduce Ada-BKB (Adaptive Budgeted Kernelized Bandit), a no-regret Gaussian process optimization algorithm for functions on continuous domains, that provably runs in $O(T^2 d_\text{eff}^2)$, where $d_\text{eff}$ is the effective dimension of the explored space, and which is typically much smaller than $T$. We corroborate our theoretical findings with experiments on synthetic non-convex functions and on the real-world problem of hyper-parameter optimization, confirming the good practical performances of the proposed approach. △ Less

Submitted 11 March, 2022; v1 submitted 16 June, 2021; originally announced June 2021.

Identification and Development of Therapeutics for COVID-19

Authors: Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey M. Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, **hui Wang, Rishi Raj Goel, YoSon Park, the COVID-19 Review Consortium, Simina M. Boca, Anthony Gitter, Casey S. Greene

Abstract: After emerging in China in late 2019, the novel Severe acute respiratory syndrome-like coronavirus 2 (SARS-CoV-2) spread worldwide and as of early 2021, continues to significantly impact most countries. Only a small number of coronaviruses are known to infect humans, and only two are associated with the severe outcomes associated with SARS-CoV-2: Severe acute respiratory syndrome-related coronavir… ▽ More After emerging in China in late 2019, the novel Severe acute respiratory syndrome-like coronavirus 2 (SARS-CoV-2) spread worldwide and as of early 2021, continues to significantly impact most countries. Only a small number of coronaviruses are known to infect humans, and only two are associated with the severe outcomes associated with SARS-CoV-2: Severe acute respiratory syndrome-related coronavirus, a closely related species of SARS-CoV-2 that emerged in 2002, and Middle East respiratory syndrome-related coronavirus, which emerged in 2012. Both of these previous epidemics were controlled fairly rapidly through public health measures, and no vaccines or robust therapeutic interventions were identified. However, previous insights into the immune response to coronaviruses gained during the outbreaks of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) have proved beneficial to identifying approaches to the treatment and prophylaxis of novel coronavirus disease 2019 (COVID-19). A number of potential therapeutics against SARS-CoV-2 and the resultant COVID-19 illness were rapidly identified, leading to a large number of clinical trials investigating a variety of possible therapeutic approaches being initiated early on in the pandemic. As a result, a small number of therapeutics have already been authorized by regulatory agencies such as the Food and Drug Administration (FDA) in the United States, and many other therapeutics remain under investigation. Here, we describe a range of approaches for the treatment of COVID-19, along with their proposed mechanisms of action and the current status of clinical investigation into each candidate. The status of these investigations will continue to evolve, and this review will be updated as progress is made. △ Less

Submitted 10 September, 2021; v1 submitted 3 March, 2021; originally announced March 2021.

Dietary Supplements and Nutraceuticals Under Investigation for COVID-19 Prevention and Treatment

Authors: Ronan Lordan, Halie M. Rando, COVID-19 Review Consortium, Casey S. Greene

Abstract: Coronavirus disease 2019 (COVID-19) has caused global disruption and a significant loss of life. Existing treatments that can be repurposed as prophylactic and therapeutic agents could reduce the pandemic's devastation. Emerging evidence of potential applications in other therapeutic contexts has led to the investigation of dietary supplements and nutraceuticals for COVID-19. Such products include… ▽ More Coronavirus disease 2019 (COVID-19) has caused global disruption and a significant loss of life. Existing treatments that can be repurposed as prophylactic and therapeutic agents could reduce the pandemic's devastation. Emerging evidence of potential applications in other therapeutic contexts has led to the investigation of dietary supplements and nutraceuticals for COVID-19. Such products include vitamin C, vitamin D, omega 3 polyunsaturated fatty acids, probiotics, and zinc, all of which are currently under clinical investigation. In this review, we critically appraise the evidence surrounding dietary supplements and nutraceuticals for the prophylaxis and treatment of COVID-19. Overall, further study is required before evidence-based recommendations can be formulated, but nutritional status plays a significant role in patient outcomes, and these products could help alleviate deficiencies. For example, evidence indicates that vitamin D deficiency may be associated with greater incidence of infection and severity of COVID-19, suggesting that vitamin D supplementation may hold prophylactic or therapeutic value. A growing number of scientific organizations are now considering recommending vitamin D supplementation to those at high risk of COVID-19. Because research in vitamin D and other nutraceuticals and supplements is preliminary, here we evaluate the extent to which these nutraceutical and dietary supplements hold potential in the COVID-19 crisis. △ Less

Submitted 3 February, 2021; originally announced February 2021.

Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure

Authors: Halie M. Rando, Adam L. MacLean, Alexandra J. Lee, Ronan Lordan, Sandipan Ray, Vikas Bansal, Ashwin N. Skelly, Elizabeth Sell, John J. Dziak, Lamonica Shinholster, Lucy D'Agostino McGowan, Marouen Ben Guebila, Nils Wellhausen, Sergey Knyazev, Simina M. Boca, Stephen Capone, Yanjun Qi, YoSon Park, Yuchen Sun, David Mai, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Jeremy P. Kamil, **hui Wang , et al. (9 additional authors not shown)

Abstract: The novel coronavirus SARS-CoV-2, which emerged in late 2019, has since spread around the world and infected hundreds of millions of people with coronavirus disease 2019 (COVID-19). While this viral species was unknown prior to January 2020, its similarity to other coronaviruses that infect humans has allowed for rapid insight into the mechanisms that it uses to infect human hosts, as well as the… ▽ More The novel coronavirus SARS-CoV-2, which emerged in late 2019, has since spread around the world and infected hundreds of millions of people with coronavirus disease 2019 (COVID-19). While this viral species was unknown prior to January 2020, its similarity to other coronaviruses that infect humans has allowed for rapid insight into the mechanisms that it uses to infect human hosts, as well as the ways in which the human immune system can respond. Here, we contextualize SARS-CoV-2 among other coronaviruses and identify what is known and what can be inferred about its behavior once inside a human host. Because the genomic content of coronaviruses, which specifies the virus's structure, is highly conserved, early genomic analysis provided a significant head start in predicting viral pathogenesis and in understanding potential differences among variants. The pathogenesis of the virus offers insights into symptomatology, transmission, and individual susceptibility. Additionally, prior research into interactions between the human immune system and coronaviruses has identified how these viruses can evade the immune system's protective mechanisms. We also explore systems-level research into the regulatory and proteomic effects of SARS-CoV-2 infection and the immune response. Understanding the structure and behavior of the virus serves to contextualize the many facets of the COVID-19 pandemic and can influence efforts to control the virus and treat the disease. △ Less

Submitted 3 December, 2021; v1 submitted 1 February, 2021; originally announced February 2021.